Extensive hospital in-ward clustering revealed by molecular characterization of influenza A virus infection.
暂无分享,去创建一个
J. Westin | M. Andersson | L. Andersson | L. Gustavsson | M. Sansone | R. Nordén | Maria E. Andersson
[1] Sunando Roy,et al. Whole-genome Sequencing Provides Data for Stratifying Infection Prevention and Control Management of Nosocomial Influenza A , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] P. Kelly,et al. Hospital-acquired influenza in an Australian tertiary Centre 2017: a surveillance based study , 2019, BMC Pulmonary Medicine.
[3] O. Ergonul,et al. Predictors of fatality in influenza A virus subtype infections among inpatients in the 2015-2016 season. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[4] I. Bakken,et al. Burden of medically attended influenza in Norway 2008‐2017 , 2019, Influenza and other respiratory viruses.
[5] J. Bloom,et al. Within-Host Evolution of Human Influenza Virus. , 2018, Trends in microbiology.
[6] J. Westin,et al. Molecular characterization of a nosocomial outbreak of influenza B virus in an acute care hospital setting , 2018, Journal of Hospital Infection.
[7] J. Bresee,et al. Progress and Remaining Gaps in Estimating the Global Disease Burden of Influenza , 2018, Emerging infectious diseases.
[8] D. Schriger,et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. , 2018, The New England journal of medicine.
[9] D. Pillay,et al. Use of Whole-Genome Sequencing in the Investigation of a Nosocomial Influenza Virus Outbreak , 2018, The Journal of infectious diseases.
[10] M. Kretzschmar,et al. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[11] A. Sing,et al. Whole genome sequencing identifies influenza A H3N2 transmission and offers superior resolution to classical typing methods , 2018, Infection.
[12] K. Johansen,et al. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015 , 2018, Vaccine.
[13] L. Rosella,et al. Acute Myocardial Infarction after Laboratory‐Confirmed Influenza Infection , 2018, The New England journal of medicine.
[14] Miguel Pinheiro,et al. INSaFLU: an automated open web-based bioinformatics suite “from-reads” for influenza whole-genome-sequencing-based surveillance , 2018, Genome Medicine.
[15] Jan Kyncl,et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.
[16] P. Vanhems,et al. Definition of healthcare‐associated influenza: A review and results from an international survey , 2017, Influenza and other respiratory viruses.
[17] Richard A. White,et al. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[18] N. Ikonen,et al. Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[19] F. Alvarez-lerma,et al. Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit. , 2017, The Journal of hospital infection.
[20] Pardis C Sabeti,et al. Genomic Analysis of Viral Outbreaks. , 2016, Annual review of virology.
[21] P. Vanhems,et al. Nosocomial influenza: encouraging insights and future challenges , 2016, Current opinion in infectious diseases.
[22] C. Reed,et al. Estimating Influenza Disease Burden from Population-Based Surveillance Data in the United States , 2015, PloS one.
[23] S. Olofsson,et al. Comparison of the FilmArray assay and in-house real-time PCR for detection of respiratory infection , 2014, Scandinavian journal of infectious diseases.
[24] C. Macintyre,et al. Mortality Attributable to Seasonal and Pandemic Influenza, Australia, 2003 to 2009, Using a Novel Time Series Smoothing Approach , 2013, PloS one.
[25] P. Kelly,et al. Hospital‐acquired influenza in an Australian sentinel surveillance system , 2013, The Medical journal of Australia.
[26] Hong Zhou,et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] R. Jiménez-García,et al. Pandemic influenza hospitalization in Spain (2009): Incidence, in-hospital mortality, comorbidities and costs , 2012, Human vaccines & immunotherapeutics.
[28] A. Osterhaus,et al. Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis. , 2011, Vaccine.
[29] Benjamin J Cowling,et al. Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections , 2010, The Journal of infectious diseases.
[30] B. Cowling,et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] Derek A T Cummings,et al. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. , 2009, The New England journal of medicine.
[32] Liam Smeeth,et al. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. , 2009, The Lancet. Infectious diseases.
[33] Stefan Gravenstein,et al. Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] Margaret A Dudeck,et al. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.
[35] Cécile Viboud,et al. Trends for Influenza-related Deaths during Pandemic and Epidemic Seasons, Italy, 1969–2001 , 2007, Emerging infectious diseases.
[36] F. Hayden,et al. Influenza in the acute hospital setting. , 2002, The Lancet. Infectious diseases.
[37] L. Grohskopf,et al. Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] Nicholas S. Kelley,et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.
[39] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[40] M. Pallen,et al. Outbreaks: Defi Nition and Classifi Cation Genomics and Outbreak Investigation: from Sequence to Consequence , 2022 .